Hervolution pitch at Novo BII demo-day by Peter J. Holst

Hervolution treats cancer by target tumor virus within the human genome. In this video you can learn more about the company, where Hervolution is presented by Associate Professor Peter Johannes Holst.

Related news

peter-johannes-holst
DEMODAY
_DSC2407final
inprotherblog